SCHEMBL23090379

SCHEMBL23090379

COc1cc2c(cc1C(=O)Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1)CCCCC2

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 5/20 0.78
▸ MEN1 O00255 5/20 0.49
▸ KMT2A Q03164 5/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ LMNA P02545 3/20 0.49
▸ RAB9A P51151 3/20 0.49
▸ RORC P51449 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ NPC1 O15118 3/20 0.47
▸ NR1H4 Q96RI1 1/20 0.45
▸ PPARA Q07869 1/20 0.45
▸ MAPK1 P28482 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ AVPR2 P30518 1/20 0.43
▸ GPR27 Q9NS67 1/20 0.43
▸ POLB P06746 2/20 0.43
▸ AHR P35869 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23090367 0.87 DHODH (1.00) DHODHMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL23651315 0.87 DHODH (0.59) DHODHMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL23090382 0.86 DHODH (1.00) DHODHMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL23090385 0.83 DHODH (0.70) DHODHMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL23090416 0.81 DHODH (1.00) DHODHMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL21468505 0.81 DHODH (0.75) DHODHMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL23090371 0.79 DHODH (0.71) DHODHMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL31077969 0.77 RORC (0.66) MEN1KMT2ASMN1; SMN2LMNARAB9A
SCHEMBL23651305 0.76 DHODH (0.77) DHODHMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL23090389 0.76 DHODH (0.76) DHODHMEN1KMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS ZC3HAV1, MAVS, ZC3HAV1L DHODH 344/4885MEN1 2888/4885KMT2A 3836/4885
US-11066357-B2 Benzoannulene derivatives as antiviral agents ZC3HAV1, MAVS, ZC3HAV1L DHODH 344/4885MEN1 2888/4885KMT2A 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback